Coastlands Capital LP buys $805,945 of Pasithea Therapeutics Corp. (KTTA) as a 10% owner
The 10% owner paid an average of $0.4833 a share, according to a Form 4 filed with the SEC on Nov 17.
A Form 4 filed on Nov 17 shows Coastlands Capital LP, a holder of more than 10% of Pasithea Therapeutics Corp., buying 1,667,514 shares worth $805,945 between Nov 13 and Nov 17, at about $0.4833 each.
The purchase was made in the open market, not through an award, an option exercise or a plan. The trade was reported within two business days, as Section 16 requires.
No other open-market purchase at Pasithea Therapeutics Corp. was reported in the previous 90 days. After the trade, the filing lists 5,502,549 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Pasithea Therapeutics Corp. (KTTA) |
|---|---|
| Insider | Coastlands Capital LP |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 1,667,514 |
| Average price | $0.4833 |
| Value | $805,945 |
| Trade dates | Nov 13 to Nov 17, 2026 |
| Filed with the SEC | Nov 17, 2026, 8:42 PM ET |
| Shares held after | 5,502,549 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
See all insider activity at Pasithea Therapeutics Corp. · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.